Delivery Order SPE2DB22D1202-SPE2DB25FVLW4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,080.32. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a $27,237.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of July 21, 2025. This non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery is designated for performance at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $68,990 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed price delivery order supports the federal government's pharmaceutical supply chain with no set-aside designation applied. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes with a ceiling value of $1,034.85. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $3,449.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 mcg/0.5 mL syringes. This non-competitive delivery order represents a single-line purchase of 0.5 mL syringes, with performance scheduled for completion by September 5, 2025. The contract will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.85 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 5, 2025, with completion expected by August 6, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location....
- The Defense Logistics Agency awarded a $2,859.80 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive range of...
- The Defense Logistics Agency awarded a $4,584.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement for military medical supply needs. This non-competitive delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $8,140.82 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, classified as a Firm Fixed Price contract, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a routine pharmaceutical supply transaction executed through AmerisourceBergen's existing contract...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLW4Delivery Order
The Defense Logistics Agency awarded a $27,596 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes under a firm fixed-price contract. The award was made on September 19, 2025, with an ultimate completion date of September 22, 2025, and represents a non-competitive, non-set-aside delivery order. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and primary distribution hub for federal medical supply operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026. The parent contract enables the contractor to supply a broad range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems globally. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its critical role as a primary pharmaceutical vendor for the Defense Health Agency and other government healthcare customers, with particular strength in delivering both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.6k | 9/19/25 |